434 related articles for article (PubMed ID: 17072331)
41. Heritable defects of the human TLR signalling pathways.
Puel A; Yang K; Ku CL; von Bernuth H; Bustamante J; Santos OF; Lawrence T; Chang HH; Al-Mousa H; Picard C; Casanova JL
J Endotoxin Res; 2005; 11(4):220-4. PubMed ID: 16176658
[TBL] [Abstract][Full Text] [Related]
42. Mutations of CARD11 but not TNFAIP3 may activate the NF-kappaB pathway in primary CNS lymphoma.
Montesinos-Rongen M; Schmitz R; Brunn A; Gesk S; Richter J; Hong K; Wiestler OD; Siebert R; Küppers R; Deckert M
Acta Neuropathol; 2010 Oct; 120(4):529-35. PubMed ID: 20544211
[TBL] [Abstract][Full Text] [Related]
43. NF-kappaB in photodynamic therapy: discrepancies of a master regulator.
Matroule JY; Volanti C; Piette J
Photochem Photobiol; 2006; 82(5):1241-6. PubMed ID: 16719545
[TBL] [Abstract][Full Text] [Related]
44. NF-κB: where did it come from and why?
Gilmore TD; Wolenski FS
Immunol Rev; 2012 Mar; 246(1):14-35. PubMed ID: 22435545
[TBL] [Abstract][Full Text] [Related]
45. Alternative pathways of NF-kappaB activation: a double-edged sword in health and disease.
Xiao G; Rabson AB; Young W; Qing G; Qu Z
Cytokine Growth Factor Rev; 2006 Aug; 17(4):281-93. PubMed ID: 16793322
[TBL] [Abstract][Full Text] [Related]
46. Transcription factor NF-kappaB regulation of renal fibrosis during ureteral obstruction.
Morrissey J; Klahr S
Semin Nephrol; 1998 Nov; 18(6):603-11. PubMed ID: 9819151
[TBL] [Abstract][Full Text] [Related]
47. Nuclear factor-kappa B pathways in Drosophila.
Minakhina S; Steward R
Oncogene; 2006 Oct; 25(51):6749-57. PubMed ID: 17072326
[TBL] [Abstract][Full Text] [Related]
48. FKBP51 and the NF-κB regulatory pathway in cancer.
Romano S; Mallardo M; Romano MF
Curr Opin Pharmacol; 2011 Aug; 11(4):288-93. PubMed ID: 21565553
[TBL] [Abstract][Full Text] [Related]
49. NFkappaB pathway: a good signaling paradigm and therapeutic target.
Tergaonkar V
Int J Biochem Cell Biol; 2006; 38(10):1647-53. PubMed ID: 16766221
[TBL] [Abstract][Full Text] [Related]
50. NF-kappaB and the immune response.
Hayden MS; West AP; Ghosh S
Oncogene; 2006 Oct; 25(51):6758-80. PubMed ID: 17072327
[TBL] [Abstract][Full Text] [Related]
51. Potential pharmacological control of the NF-κB pathway.
Sethi G; Tergaonkar V
Trends Pharmacol Sci; 2009 Jun; 30(6):313-21. PubMed ID: 19446347
[TBL] [Abstract][Full Text] [Related]
52. The role and regulation of the nuclear factor kappa B signalling pathway in human labour.
Lappas M; Rice GE
Placenta; 2007; 28(5-6):543-56. PubMed ID: 16843526
[TBL] [Abstract][Full Text] [Related]
53. NF-kappaB and the regulation of hematopoiesis.
Bottero V; Withoff S; Verma IM
Cell Death Differ; 2006 May; 13(5):785-97. PubMed ID: 16528384
[TBL] [Abstract][Full Text] [Related]
54. Amiloride and the regulation of NF-kappaB: an unsung crosstalk and missing link between fluid dynamics and oxidative stress-related inflammation--controversy or pseudo-controversy?
Haddad JJ
Biochem Biophys Res Commun; 2005 Feb; 327(2):373-81. PubMed ID: 15629126
[TBL] [Abstract][Full Text] [Related]
55. NEMO, NFkappaB signaling and incontinentia pigmenti.
Nelson DL
Curr Opin Genet Dev; 2006 Jun; 16(3):282-8. PubMed ID: 16647846
[TBL] [Abstract][Full Text] [Related]
56. NF-κB signaling in skeletal muscle health and disease.
Peterson JM; Bakkar N; Guttridge DC
Curr Top Dev Biol; 2011; 96():85-119. PubMed ID: 21621068
[TBL] [Abstract][Full Text] [Related]
57. Rel/NF-kappa B/I kappa B signal transduction in the generation and treatment of human cancer.
Gilmore T; Gapuzan ME; Kalaitzidis D; Starczynowski D
Cancer Lett; 2002 Jul; 181(1):1-9. PubMed ID: 12430173
[TBL] [Abstract][Full Text] [Related]
58. Formal agent-based modelling of intracellular chemical interactions.
Pogson M; Smallwood R; Qwarnstrom E; Holcombe M
Biosystems; 2006 Jul; 85(1):37-45. PubMed ID: 16581178
[TBL] [Abstract][Full Text] [Related]
59. The many faces of the copper metabolism protein MURR1/COMMD1.
de Bie P; van de Sluis B; Klomp L; Wijmenga C
J Hered; 2005; 96(7):803-11. PubMed ID: 16267171
[TBL] [Abstract][Full Text] [Related]
60. Septicemia without sepsis: inherited disorders of nuclear factor-kappa B-mediated inflammation.
von Bernuth H; Puel A; Ku CL; Yang K; Bustamante J; Chang HH; Picard C; Casanova JL
Clin Infect Dis; 2005 Nov; 41 Suppl 7():S436-9. PubMed ID: 16237643
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
